Evidence map›Paper›PMID 30048544›Full record

ArticlePloS one2018

The brave blue world: Facebook flow and Facebook Addiction Disorder (FAD).

Julia Brailovskaia, Elke Rohmann, Hans-Werner Bierhoff, Jürgen Margraf

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. "In Flow"! Why Do Users Share Fake News about Environmentally Friendly Brands on Social Media?International journal of environmental research and public health · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Julia BrailovskaiaMental Health Research and Treatment Center, Ruhr-Universität Bochum, Bochum, Germany.ORCID 0000-0001-7607-1305
Elke RohmannDepartment of Social Psychology, Ruhr-Universität Bochum, Bochum, Germany.
Hans-Werner BierhoffDepartment of Social Psychology, Ruhr-Universität Bochum, Bochum, Germany.
Jürgen MargrafMental Health Research and Treatment Center, Ruhr-Universität Bochum, Bochum, Germany.ORCID 0000-0001-5207-7016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study investigated the relationship between flow experienced when using Facebook (Facebook flow; i.e., experience of intensive enjoyment and pleasure generated by Facebook use due to which the Facebook activity is continued even at high costs of this behavior) and Facebook Addiction Disorder (FAD). In a sample of 398 Facebook users (age: M (SD) = 33.01 (11.23), range: 18-64), the significant positive association between Facebook flow and FAD was positively moderated by the intensity of Facebook use. Exploratory factor analysis revealed that all six items assessing FAD loaded on the same factor as two items belonging to the subscale telepresence of Facebook flow. Therefore, the close link between Facebook flow and FAD may in particular result from the immersion in an attractive online world created by Facebook, where users escape to forget their everyday obligations and problems. Present results provide first evidence that Facebook flow may be an anteceded of FAD and indicate the mechanisms that may contribute to its development and maintenance. Practical applications for future studies and limitations of present results are discussed.

Indexed as

Social MediaAdolescentAdultAffectAnxietyBehavior, AddictiveDepressionFemaleHumansMaleMiddle AgedPleasureSex FactorsYoung Adult

Identifiers

PMID30048544
PMCPMC6062136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.